Skip to main content

Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CBE ID
0081e
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
Next Maintenance Cycle
Fall 2025
1.6 Measure Description

Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB or ARNI therapy either within a 12-month period when seen in the outpatient setting OR at each hospital discharge

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      1.9 Care Setting
      1.14 Numerator

      Patients who were prescribed ACE inhibitor or ARB or ARNI therapy either within a 12-month period when seen in the outpatient setting OR at each hospital discharge

      1.15 Denominator

      All patients aged 18 years and older with a diagnosis of heart failure with a current or prior LVEF < 40%

      Exclusions

      Denominator Exceptions:
      Documentation of medical reason(s) for not prescribing ACE inhibitor or ARB or ARNI therapy (e.g., hypotensive patients who are at immediate risk of cardiogenic shock, hospitalized patients who have experienced marked azotemia, allergy, intolerance, other medical reasons).

      Documentation of patient reason(s) for not prescribing ACE inhibitor or ARB or ARNI therapy (e.g., patient declined, other patient reasons).

      Documentation of system reason(s) for not prescribing ACE inhibitor or ARB or ARNI therapy (e.g ., other system reasons).

      Most Recent Endorsement Activity
      Endorsed Cardiovascular Spring Cycle 2019
      Initial Endorsement
      Last Updated
      Steward Organization
      American Heart Association
      Steward POC email
      Steward Organization Copyright

      Copyright 2019 American College of Cardiology, American Heart Association and American Medical Association. All Rights Reserved.

                Use
                6.1.2 Current or Planned Use(s)
                Planned Use
                6.1.3 Current Use(s)
                  Public Comments